drugset
drugset / Trial / NCT00517504

Methylphenidate Study in Young Children With Developmental Disorders

NCT00517504 ↗

Phase 4 Completed 48 enrolled University of Arizona National Institute of Mental Health (NIMH) · collab
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine if methylphenidate (a common brand name is Ritalin), a medicine used for treating older children with Attention Deficit and Hyperactivity Disorder (ADHD), is also safe and helpful for problems related to symptoms of ADHD in young children with Developmental Disorders (DD)

Timeline

Start
2001-05
Primary completion
2008-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule — —

Indications

attention deficit-hyperactivity disorder